Business
Chicago Capital Trims $12.5M Stake in Surgically Focused Robotic Firm PROCEPT BioRobotics
Amid a steep 60% annual share price decline, investment firm Chicago Capital has significantly reduced its position in PROCEPT BioRobotics, a developer of robotic systems for urological surgery, signaling a portfolio risk reassessment.